Median Technologies seeks FDA approval for iBiopsy LCS solution
Median Technologies has filed a 513(g) submission with the US Food and Drug Administration (FDA) seeking regulatory approval for its iBiopsy lung cancer screening (LCS) solution. The iBiopsy